- 
  
    FederalNNDSS - TABLE 1Q. Hepatitis B, perinatal infection to Hepatitis C (viral, acute), ProbableU.S. Department of Health & Human Services — NNDSS - TABLE 1Q. Hepatitis B, perinatal infection to Hepatitis C (viral, acute), Probable - 2019. In this Table, provisional cases* of notifiable diseases are...
- 
  
    FederalHHS COVID-19 Small Area Estimations Survey - Primary Vaccine Series - Wave 28U.S. Department of Health & Human Services — The goal of the Monthly Outcome Survey (MOS) Small Area Estimations (SAE) is to generate estimates of the proportions of adults, by county and month, who were in the...
- 
  
    FederalNNDSS - Table II. VibriosisU.S. Department of Health & Human Services — NNDSS - Table II. Vibriosis - 2018. In this Table, provisional cases of selected notifiable diseases (≥1,000 cases reported during the preceding year), and selected...
- 
  
    FederalBlog | The Data Imperative: Why Data Sharing Matters to Your OrganizationU.S. Department of Health & Human Services — This blog post was posted on September 17, 2018.
- 
  
    FederalProduct Data for Newly Reported Drugs in the Medicaid Drug Rebate ProgramU.S. Department of Health & Human Services — The Table below, updated weekly, contains newly reported, active covered outpatient drugs which were reported by participating drug manufacturers since the last...
- 
  
    FederalNNDSS - TABLE 1DD. Rubella to Rubella, congenital syndromeU.S. Department of Health & Human Services — NNDSS - TABLE 1DD. Rubella to Rubella, congenital syndrome - 2019. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S....
- 
  
    FederalCOVID-19 State Profile Report - New MexicoU.S. Department of Health & Human Services — After over two years of public reporting, the State Profile Report will no longer be produced and distributed after February 2023. The final release was on February...
- 
  
    FederalHHS COVID-19 Small Area Estimations Survey - Primary Vaccine Series - Wave 26U.S. Department of Health & Human Services — The goal of the Monthly Outcome Survey (MOS) Small Area Estimations (SAE) is to generate estimates of the proportions of adults, by county and month, who were in the...
- 
  
    FederalNNDSS - Table 1B. Arboviral diseases, neuroinvasive and non-neuroinvasive, Jamestown Canyon virus disease to Powassan virus diseaseU.S. Department of Health & Human Services — NNDSS - Table 1B. Arboviral diseases, neuroinvasive and non-neuroinvasive, Jamestown Canyon virus disease to Powassan virus disease - 2019. In this Table, provisional...
- 
  
    FederalBlog | COVID-19 TOPx Momentum Continues with the Open Data for Good ChallengeU.S. Department of Health & Human Services — Following the COVID-19 TOPx Technology Development Sprint, HHS and the U.S. Census Bureau continue data-driven collaboration through the Open Data for Good Grand...
- 
  
    FederalNNDSS - Table II. Giardiasis to Haemophilus influenzaU.S. Department of Health & Human Services — NNDSS - Table II. Giardiasis to Haemophilus influenza - 2017. In this Table, provisional cases of selected notifiable diseases (≥1,000 cases reported during the...
- 
  
    FederalBlog | Demand-Driven Open Data: How to get the health data you needU.S. Department of Health & Human Services — This blog post was posted by David Portnoy on September 22, 2015.
- 
  
    FederalNNDSS - TABLE 1Z. Pertussis to Poliomyelitis, paralyticU.S. Department of Health & Human Services — NNDSS - TABLE 1Z. Pertussis to Poliomyelitis, paralytic - 2020. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S....
- 
  
    FederalNNDSS - TABLE 1I. Cryptosporidiosis to CyclosporiasisU.S. Department of Health & Human Services — NNDSS - Table 1I. Cryptosporidiosis to Cyclosporiasis - 2019. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S....
- 
  
    FederalProduct Data for Newly Reported Drugs in the Medicaid Drug Rebate Program 2023-12-04-to-2023-12-10U.S. Department of Health & Human Services — The data below contains newly reported, active covered outpatient drugs which were reported by participating drug manufacturers since the last quarterly update of the...
